Predicate |
Object |
contentType |
Clinical Trial|Letter |
endingPage |
1 |
issn |
0378-6323 |
issueIdentifier |
5 |
pageRange |
360-1 |
publicationName |
Indian Journal of Dermatology, Venereology and Leprology |
startingPage |
360 |
bibliographicCitation |
Nigam PK, Anant S. An evaluation of the efficacy and safety of tazarotene (0.1%) cream in acne vulgaris. Indian J Dermatol Venereol Leprol. 2005 Sep;71(5):360–1. doi: 10.4103/0378-6323.16792. PMID: 16394466. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f45ddec8d11f7d0b77f89ae27fb69520 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c908d39a0c68b839febd622a576da55 |
date |
200509 |
identifier |
https://pubmed.ncbi.nlm.nih.gov/16394466 https://doi.org/10.4103/0378-6323.16792 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27595 https://portal.issn.org/resource/ISSN/0378-6323 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
An evaluation of the efficacy and safety of tazarotene (0.1%) cream in acne vulgaris |
discusses |
http://id.nlm.nih.gov/mesh/M0014839 http://id.nlm.nih.gov/mesh/M0006057 http://id.nlm.nih.gov/mesh/M0230113 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D009539Q000627 http://id.nlm.nih.gov/mesh/D003879Q000627 http://id.nlm.nih.gov/mesh/D000152Q000188 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D016896 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6777 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5381 |